As of 4:00pm ET
| -0.0012 / -0.25%|
The 2 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 1.75, with a high estimate of 2.50 and a low estimate of 1.00. The median estimate represents a +265.50% increase from the last price of 0.48.
The current consensus among 4 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.